Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Inflazome announces acquisition by Roche - PharmiWeb.com
Inflazome | Forbion
Forbion leads €40m financing in Inflazome Ltd - European Biotechnology ...
When Inflazome becomes Roche – The Science of Parkinson's
Roche bulks up in inflammation with €380m Inflazome acquisition ...
Inflazome Patents - Insights & Stats (Updated 2025)
Ireland biotech startup Inflazome acquired by Roche for €380 million ...
Roche acquires Irish biotech firm Inflazome for $449m
Roche buys Inflazome for $445 million
Roche Bulks Up In NLRP3 With €380m Inflazome Buy
Roche acquires Irish biotechnology company Inflazome for €380m
Roche buys Inflazome as pharma interest in targeting inflammation grows ...
Roche Buys NLRP3 Inflammasome Inhibitors Developer Inflazome
We're very excited to announce the acquisition of Inflazome today. This ...
Inflazome snapped up in €380m deal with pharma giant Roche
Roche acquiring Inflazome for $448M up front | 2020-09-21 | BioWorld
Inflazome | Case study | Invest Europe
Finding The Exit: Forbion On Roche’s Acquisition Of Inflazome
Inflazome chief Matt Cooper injects drug hopes with €380m Roche deal
Inflazome - Crunchbase Company Profile & Funding
Roche se porte acquéreur de l'irlandais Inflazome - SWI swissinfo.ch
Queensland biotech startup Inflazome raises $63 million to change the ...
Roche schluckt Inflazome für 380 Mio. Euro
Forbion portfolio company, Inflazome acquired by Roche | Forbion ...
Inflazome raises €40M to get NLRP3 drug into humans | Fierce Biotech
Inflazome secures orphan drug status for Inzomelid – The Irish Times
Roche übernimmt irische Biotechfirma Inflazome | Südostschweiz
Inflazome brings on ex-Novartis executive as CMO after €40M VC round ...
Inflazome success story is an inspiration to Irish business | Business Post
Inflazome Ltd. (英夫拉索姆有限公司) - 药物管线_专利_临床试验_投融营收_最新药物:Somalix，Inzomelid ...
Our Parkinson's Place: Inflazome grabs Fox Foundation funding for ...
Dublin Medical Startup Inflazome Raises €15m - Business Plus
Irish biotech Inflazome in €40m fundraising – The Irish Times
Congratulations to Dr Fleur Garton, winner of the IMB Inflazome ...
Dublin pharma start-up Inflazome raises €40m
Inflazome Co-founder and CEO Matt Cooper Named Cross-Field Highly Cited ...
Inflazome grabs Fox Foundation funding for Parkinson’s R&D | Fierce Biotech
Roche in €380m Inflazome acquisition
Inflazome secures $1m research grant from the Michael J Fox Foundation
Dublin-based Inflazome has secured €40m to take its commercially 'risky ...
Forbion Leads €40m Series B Financing in Inflazome to Develop NLRP3 ...
The Journey to selling Inflazome for 380 Million #neuroscience #podcast ...
Inflazome raises €40m in new funding round
Commercialisation Impact Award - Inflazome Ltd. & Trinity College ...
生物技术公司Inflazome获100万美元融资，开发小分子药物治疗炎症性疾病-动脉网
Inflazome’s Somalix Demonstrates Positive Safety, Tolerability and ...
BIO 2019
The ibuprofen post – The Science of Parkinson's
Roche Confirms Pharma Appetite for Inflammatory Disease Treatments
火爆|罗氏宣布首付款3.8亿欧元收购Inflazome获得NLRP3抑制剂_临床
At last: Selnoflast – The Science of Parkinson's
Roche Dives into NLRP3 Inflammasome Inhibition with Acquisition of ...
Selnoflast(Selnoflast) - 药物靶点：NLRP3_在研适应症：哮喘，关节炎，心血管疾病_专利_临床_研发
Inflazome's Anti-Inflammatory Treatments Get €40M Boost in Series B Led ...
Roche pays €380M for NLRP3 biotech Inflazome, claiming a leading ...
Roche Spends $451 Million to Acquire Inflazome's NLRP3 Program | The ...
Inflazome’s Matt Cooper named best emerging entrepreneur – The Irish Times
Samsung/AZ Deal; Gyroscope’s GT005; Inflazome's Buyout; & much more
BIO 2022
New UQ drug breakthrough could accelerate Parkinson's treatment | Gold ...
Inzomelid completes Phase I studies and shows positive results in the ...
Venner Shipley’s world leading inflammasome client, Inflazome, acquired ...
«Инфлейзоум» (Inflazome) | МОСМЕДПРЕПАРАТЫ
FDA grants orphan drug designation for Inflazome’s Inzomelid to treat ...
Discovery | IMB Inflammasome Lab
selnoflast – The Science of Parkinson's
靶向NLRP3炎症小体的策略
Partner with us - Institute for Molecular Bioscience - University of ...
罗氏收购4.48亿首付Inflazome | 美中药源
14 April 2, 2019 | Company Update The Future of IL - 1 β Blocking May ...
Roche überzeugt mit Zukauf und Studie
愛爾蘭創企Inflazome獲1700萬美元A輪融資，醫藥巨頭諾華領投 - 每日頭條
炎症性疾病领域新进展，Inflazome新一轮融资用以推进主要药物临床试验-动脉网
Institute for Molecular Bioscience - University of Queensland
KTI Connect on Twitter: "[3] #KTIAWARDS COMMERCIALISATION FINALIST ...
When start-ups & biotech collide
7月被FDA授予孤儿药资格，9月以3.8亿欧元预付款被收购，Inflazome的NLRP3抑制剂能否在未来大放异彩？ - 药时代DrugTimes
BioCentury - Biotechs explore the next generation of inflammasome ...
Kasia Fennell (Oficjalska) on LinkedIn: Swiss drug giant Roche pays € ...
INFLAZOME: FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid ...
“When we did the deal, I went and bought a nice bottle of wine and a ...
We are delighted to announce that this week Dr. David Miller joined the ...
Roche’s inavolisib meets primary endpoint of PFS in Phase 3 breast cancer
Targeting the NLRP3 inflammasome for inflammatory disease therapy ...
Schematic diagram illustrating the mechanisms of NLRP3 inflammasome ...
Mechanism and Regulation of NLRP3 Inflammasome Activation: Trends in ...
.jpg%3FVersionId%3DfOol5r98kfOCqREOpAvp30MNQZJejbKU&w=3840&q=75)
%3Aquality(70)%2Fcloudfront-eu-central-1.images.arcpublishing.com%2Firishtimes%2F32LTG46PAQHFMZTYTRU72XTGWM.jpg&w=3840&q=75)
